Stay updated on Bictegravir vs Dolutegravir in HIV/HepB Co-Infection Clinical Trial

Sign up to get notified when there's something new on the Bictegravir vs Dolutegravir in HIV/HepB Co-Infection Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Bictegravir vs Dolutegravir in HIV/HepB Co-Infection Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label advances from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T15:17:48.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden message, blocking access to the study details and indicating that the page cannot be viewed at this time.
    Difference
    20%
    Check dated 2026-09-21T20:40:18.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    New revision v3.6.6 for the study protocol and SAP has been added, replacing the earlier v3.6.5. The updated documents are now available in the Study Documents section.
    Difference
    0.1%
    Check dated 2026-08-31T17:28:38.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The revision label on the page updates from v3.6.4 to v3.6.5, signaling a new site build. This is a technical version update rather than a modification to the study content or its results.
    Difference
    0.1%
    Check dated 2026-08-10T10:55:34.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.4 and no longer shows Revision: v3.6.3. This indicates the document or component has been updated to a newer revision without changing the trial details.
    Difference
    0.1%
    Check dated 2026-07-27T05:49:24.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    Footer revision label updated to v3.6.3, replacing the previous v3.6.2. This indicates a deployment/update of the page.
    Difference
    0.1%
    Check dated 2026-07-05T13:23:06.000Z thumbnail image

Stay in the know with updates to Bictegravir vs Dolutegravir in HIV/HepB Co-Infection Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Bictegravir vs Dolutegravir in HIV/HepB Co-Infection Clinical Trial page.